| 000 | 01503 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517162613.0 | ||
| 264 | 0 | _c20181126 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1674-8018 | ||
| 024 | 7 |
_a10.1007/s13238-017-0438-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKang, Ciming | |
| 245 | 0 | 0 |
_aA novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys. _h[electronic resource] |
| 260 |
_bProtein & cell _c01 2018 |
||
| 300 |
_a130-134 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntibodies, Viral _xtherapeutic use |
| 650 | 0 | 4 |
_aHepatitis B virus _ximmunology |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Engineering |
| 650 | 0 | 4 |
_aReceptors, Fc _xmetabolism |
| 700 | 1 | _aXia, Lin | |
| 700 | 1 | _aChen, Yuanzhi | |
| 700 | 1 | _aZhang, Tianying | |
| 700 | 1 | _aWang, Yiwen | |
| 700 | 1 | _aZhou, Bing | |
| 700 | 1 | _aYou, Min | |
| 700 | 1 | _aYuan, Quan | |
| 700 | 1 | _aTzeng, Chi-Meng | |
| 700 | 1 | _aAn, Zhiqiang | |
| 700 | 1 | _aLuo, Wenxin | |
| 700 | 1 | _aXia, Ningshao | |
| 773 | 0 |
_tProtein & cell _gvol. 9 _gno. 1 _gp. 130-134 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s13238-017-0438-y _zAvailable from publisher's website |
| 999 |
_c27337971 _d27337971 |
||